Brind.

Piper Sandler raised its price target for IDEXX Laboratories following the company's strong Q2 results.

1 report, 1 independent Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Piper Sandler raised its price target for IDEXX Laboratories following the company's strong Q2 results.

Who's involved

What this event is mainly about
IDEXX Laboratories, Inc.Piper Sandler Companies

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyPiper Sandler Raises IDEXX Laboratories (IDXX) PT to $700, Cites Strong Q2 Results IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best performing S&P 500 stocks to buy now. On August 11, Piper S